Cancer Drug for Alzheimer's Treatment Camp Lejeune NC
Camp Lejeune, NC
Medical School: Eastern Va Med Sch Of The Med Coll Of Hampton Roads, Norfolk Va 23501
Graduation Year: 1993
Winston Salem, NC
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1979
Accepting New Patients: Yes
2.4, out of 5 based on 6, reviews.
Neurology, Alzheimer's Specialist
Medical School: Univ Of Pittsburgh Sch Of Med, Pittsburgh Pa 15261
Graduation Year: 1989
Hospital: Carolinas Med Ctr, Charlotte, Nc; Presbyterian Hospital, Charlotte, Nc; Presbyterian Hosp Matthews, Matthews, Nc
Group Practice: Mecklenburg Neurological Associates
Medical School: Univ Of Va Sch Of Med, Charlottesville Va 22908
Graduation Year: 1983
Medical School: Univ Of Pa Sch Of Med, Philadelphia Pa 19104
Graduation Year: 1972
Hospital: Wake Med Ctr, Raleigh, Nc
Group Practice: Raleigh Neurology Assocs
Cancer Drug for Alzheimer's Treatment
TUESDAY, Sept. 8 (HealthDay News) -- New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease.
The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.
"People often joke that they must have Alzheimer's because they can't remember where they put their keys, but for a person with the disease, this type of short-term memory loss is extremely debilitating," study author Ottavio Arancio, an associate professor of pathology and cell biology at Columbia University Medical Center, said in a news release.
The researchers examined a cancer drug from a family of compounds called HDAC inhibitors. The drug tinkers with DNA, and in the mice the researchers studied it appeared to make it easier for neurons in the brain to manufacture new proteins.
That process is critical in the process of recording new memories.
"Because this type of drug has already been approved for some cancer patients, we hope that clinical trials for Alzheimer's disease can start in about three to four years," said co-author Mauro Fa, an associate research scientist at Columbia.
The findings appear in the September issue of the Journal of Alzheimer's Disease.
Learn more about memory from McGill University.
SOURCE: Columbia University, news release, Sept. 3, 2009
Copyright © 2009 ScoutNews, LLC. All rights reserved.Read Article at HealthDay.com